Physician profile
Wayne Panullo
NPI 1679616593
$4,611.90
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,353 · 2020: $538 · 2021: $1,141 · 2022: $1,580.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,059.92 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $969.54 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $680.35 | 2019-2022 | |
| Gilead Sciences, INC. | $409.39 | 2019-2022 | |
| Janssen Biotech, INC. | $335.97 | 2019-2022 | |
| Celgene Corporation | $196.97 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $93.18 | 2019-2022 | |
| Ucb, INC. | $76.05 | 2019-2020 | |
| Boston Scientific Corporation | $61.90 | 2019 | |
| Braintree Laboratories, INC. | $61.45 | 2019-2022 | |
| Alfasigma USA, INC. | $60.07 | 2020-2021 | |
| Allergan, INC. | $54.54 | 2019 | |
| Ardelyx, INC. | $53.83 | 2022 | |
| Intercept Pharmaceuticals, INC. | $52.74 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $52.34 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $51.70 | 2021-2022 | |
| Redhill Biopharma INC. | $44.63 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $39.54 | 2020-2021 | |
| Pfizer INC. | $33.36 | 2022 | |
| Daiichi Sankyo INC. | $33.03 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $30.54 | 2019 | |
| Genzyme Corporation | $28.27 | 2022 | |
| Qol Medical, LLC | $27.31 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $25.01 | 2022 | |
| Evoke Pharma, INC. | $24.61 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.43 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.31 | 2022 | |
| Shire North American Group INC | $14.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Panullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.